CHIMERIX INC Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020
Cash flows from operating activities:
Net loss
Net (loss) income
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Depreciation of property and equipment
Amortization of debt issuance costs
Amortization of discount/premium on investments
Share-based compensation
Fair value of common stock issued related to asset acquisition
Note payable related to asset acquisition
Fair value of common stock issued for license agreement
(Gain) on disposition of assets
Gain on sale of TEMBEXA
Gain on sale of equipment
Gain on sale/redemption of investments
Unrealized loss on equity investment
Lease-related amortization

Changes in operating assets and liabilities:
Accounts receivable
Inventories
Prepaid expenses and other assets
Accounts payable and accrued liabilities
Net cash used in operating activities

Cash flows from investing activities:
Purchases of property and equipment
Purchases of short-term investments
Purchases of long-term investments
Proceeds from sales of short-term investments
Proceeds from redemptions/maturities of short-term investments
Proceeds from sales of long-term investments
Proceeds from redemptions of long-term investments
Proceeds from sale of TEMBEXA
Proceeds from sale of property and equipment
Net cash provided by investing activities
Cash flows from financing activities:
Proceeds from exercise of stock options
Proceeds from employee stock purchase plan
Proceeds from issuance of common stock, net of commissions
Payments of debt issuance costs
Payment of note payable
Net cash provided by (used in) financing activities
Net increase in cash and cash equivalents
Cash and cash equivalents:
Beginning of period
End of period
Supplemental disclosure of cash flow information
Non-cash purchases of property and equipment
Non-cash issuance of stock purchase warrant

Comments